Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Naloxone injection or intranasal treatment opioid overdose treatment
Naltrexone borderline personality disorder for tardive dyskinesia people with learning difficulties preventing relapse after opioid detoxification for antipsychotic-induced weight gain gambling disorder preventing relapse after alcohol detoxification
Naranjo scale anticholinergic effects of antipsychotics Summary of psychiatric adverse effects of non-psychotropics antipsychotics in menopausal women
National Institute for Health and Care Excellence (NICE) guidelines anxiety spectrum disorders attention deficit hyperactivity disorder in children and adolescents dementia eating disorders hypercholesterolaemia panic disorder attention deficit hyperactivity disorder in adults borderline personality disorder depression generalised anxiety disorder obsessive compulsive disorder prophylaxis in bipolar disorder
Natural
Neuroleptic malignant syndrome
Neuroleptic malignant syndrome association optimal dosage treatment algorithm Neuroleptic malignant syndrome relative efficacy treatment of negative symptoms
new psychoactive substances (NPS/designer drugs) 477 Benzodiazepine misuse Drug-induced excited state
Next-steps if no response
Nicotine attention deficit hyperactivity disorder drug interactions Nicotine schizophrenia depression and anxiety movement disorders psychotropic effects smoking cessation and withdrawal symptoms
Nicotine dependence bupropion cytisine Nicotine nicotine replacement therapy varenicline electronic vaping devices Nicotine and smoking cessation treatment algorithms withdrawal symptoms
Nalmefene, alcohol dependence
Naranjo adverse drug reaction scale (adapted) 972
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness
Neurobiology of withdrawal
NICE guidelines
Nicotine preparations and doses
nicotine replacement therapy (NRT) 523-524 clinical effectiveness preparations and doses adverse effects combination of formulations
Nicotine vaping devices (vaping) 527-528 clinical effectiveness preparations and doses adverse effects Nicotine and smoking cessation
Nocturnal enuresis, management
Non-adherence lithium restarting psychotropic medications after period of non-compliance impacts rates and degrees of adherence
Non-iatrogenic benzodiazepine dependence
Non-psychotropics associated with QT prolongation (see Crediblemeds.org for latest information; this is not a complete list).
Norclozapine
Nutritional supplements anorexia nervosa fatigue in multiple sclerosis
Nocebo effects, patient expectations of treatment
non-competitive N-methyl-D-aspartate receptor antagonists
Non-nucleoside reverse transcriptase inhibitors
non-steroidal anti-inflammatory drugs (NSAIDs)
Nucleoside reverse transcriptase inhibitors, psychiatric adverse reactions